constella linaclotide 72 microgram hard capsule bottle
abbvie pty ltd - linaclotide, quantity: 0.072 mg - capsule, hard - excipient ingredients: histidine; polyvinyl alcohol; calcium chloride dihydrate; purified talc; microcrystalline cellulose; titanium dioxide; potable water; gelatin; sodium lauryl sulfate; propylene glycol; butan-1-ol; ethanol; iron oxide yellow; strong ammonia solution; iron oxide black; methanol; shellac; sulfuric acid - constella is indicated in adults for the treatment of: ? irritable bowel syndrome with constipation (ibs-c) and ? chronic idiopathic constipation (cic) when dietary fibre, laxatives and stool softeners have not been sufficient and with adequate constipation minimisation dietary support.
constella 290microgram capsules
allergan ltd - linaclotide - capsule - 290microgram
pinaloid tablet
medpro pharmaceutica (pty) ltd - tablet - see ingredients - each tablet contains cyclizine hydrochloride 50,0 mg
linzela capsule
nuvista pharma ltd - linaclotide - capsule - 72 mcg
linzess capsule
allergan inc, united states - linaclotide - capsule - 290 µg
linzess capsule
allergan inc, united states - linaclotide - capsule - 145 µg
linzela 290 capsule
nuvista pharma ltd - linaclotide - capsule - 290 mcg
linzess tablets 0.25mg (リンゼス錠0.25mg)
astellas pharama inc. - linaclotide - pale yellow tablets, diameter: approx. 6.6 mm, thickness: approx. 3.1 mm
constella
abbvie limited - linaclotide 0.145mg; ; - capsule - 145 mcg - active: linaclotide 0.145mg excipient: calcium chloride dihydrate capsugel linaclotide fl 145 (18213) hydrochloric acid hypromellose leucine microcrystalline cellulose opacode gray s-1-175002 - constella is indicated in adults for the treatment of: · irritable bowel syndrome with constipation (ibs-c) and
constella
abbvie limited - linaclotide 0.29mg; ; - capsule - 290 mcg - active: linaclotide 0.29mg excipient: calcium chloride dihydrate capsugel linaclotide gelatine s 2 (18212) hydrochloric acid hypromellose leucine microcrystalline cellulose opacode gray s-1-175002 - constella is indicated in adults for the treatment of: · irritable bowel syndrome with constipation (ibs-c) and